Zhanxiang Zhou
Co-Director, CTBR, Professor, Nutrition
Center for Translational Biomedical Research
Email Address: z_zhou@uncg.edu
Research Focus
Metabolic liver diseases
Research Overview
Dr. Zhangxiang Zhou’s laboratory examines how imbalanced dietary consumption, such as the abuse of alcohol and other hallmarks of contemporary Western life, contributes to the development of liver diseases. 1 in 10 Americans have some form of liver disease, and the number of deaths related to these diseases may be higher than we think. (Mayo Clinic researchers recently challenged CDC statistics and placed liver disease as the 8th leading cause of American deaths). With funding from the National Institutes of Health, the Zhou Research Group currently focuses on combating fatty liver disease, in which excess lipids deposit in the liver due to alcohol abuse or obesity. Unchecked fatty liver disease can progress to hepatitis (inflammation), liver cirrhosis (scarring), and liver failure. CTBR researchers in the Zhou group are exploring the biological causes and progression of fatty liver disease, methods for early diagnosis, and particular dietary and pharmaceutical interventions that could prevent and even reverse damages caused by the disease.
CURRENT PROJECT-ALDEHYDE TOXICITY
Investigating the mechanisms by which aldehydes impair cell function and induce organ damage, and developing strategies to speed up aldehyde clearance. Alcohol consumption exerts toxic effects on the body with gut, liver and brain as the major target organs. Aldehyde generation is a feature of alcohol intoxication. While alcohol metabolism generates acetaldehyde, lipid peroxidation produces lipid aldehydes such as 4-hydroxynonenal and malondialdehyde. Accumulation of aldehydes has been detected in intestinal contents, liver, blood and brain after alcohol intoxication. This project aims to investigate the molecular mechanisms by which aldehydes mediate alcohol-induced cytotoxicity at the gut-liver-brain axis.
CURRENT PROJECT-LIPOTOXICITY
Lipid accumulation is one of the most fundamental cellular disorders in the development of alcoholic liver disease. During the past decades, great efforts have been paid to understand the mechanisms by which alcohol abuse induces hepatic accumulation of lipid droplets, particularly triglyceride. However, increasing evidence suggests that free fatty acids are more toxic than triglyceride. Therefore, it is important to understand the mechanism by which alcohol abuse increases the hepatic fatty acid level and by which fatty acids induce cell injury. This project aims to investigate the mechanisms by which alcohol abuse increases the hepatic fatty acid level and by which fatty acids induce cell injury. We are also interested in understanding of how dietary factors may modulate fatty acid homeostasis in the liver.
CURRENT PROJECT-ORGAN INTERACTIONS
Increasing evidence support a concept that extra-hepatic factors critically involve in the pathogenesis of liver diseases. The most well studied factors include endotoxin penetration from the intestine and excess fatty acid release from the white adipose tissue. Only trace amount of intestinal endotoxin can penetrate to the blood at normal condition. However, blood endotoxin level will be elevated, namely endotoxemia, at disease condition such as alcoholic and nonalcoholic liver disease. Endotoxin plays critical role in development of hepatitis by triggering production of proinflammatory cytokine. On the other hand, lipids stored in the white adipose tissue could be released and deposited in the liver at alcohol abuse or obesity conditions. The objectives of this project are to investigate the mechanisms by which extra-hepatic factor are generated and by which these factors contribute to the pathogenesis of liver damage
CURRENT PROJECT-DIETARY INTERVENTIONS
Exploring dietary interventions to prevent or treat liver diseases. Liver is the major organ responsible for metabolism in the body. The metabolic function of the liver can be disturbed at disease conditions such as alcohol exposure and toxicant exposure. Functional disorder of the liver may, in turn, affect nutrient absorption and metabolism, leading to nutritional deficiency. Previous reports from our research group have shown that alcohol abuse zinc deficiency and improvement of zinc homeostasis by dietary zinc supplementation ameliorates alcoholic liver disease. Other dietary factors such as niacin and saturated fat also have beneficial effects on alcoholic liver disease. The goal of this project is to screen nutrients and natural products which may protect against liver disease work via intrahepatic or extrahepatic mechanisms.
Publications
- Dong H, Guo W, Zhou Z. BAX/MLKL signaling contributes to lipotoxicity-induced lysosomal membrane permeabilization in alcohol-associated liver disease. Autophagy. 2024 Apr;20(4):958-959. doi: 10.1080/15548627.2023.2221989. Epub 2023 Jun 13. PMID: 37289043.
- Dong H, Guo W, Yue R, Sun X, Zhou Z. Nuclear Nicotinamide Adenine Dinucleotide Deficiency by Nmnat1 Deletion Impaired Hepatic Insulin Signaling, Mitochondrial Function, and Hepatokine Expression in Mice Fed a High-Fat Diet. Lab Invest. 2024 Mar;104(3):100329. doi: 10.1016/j.labinv. 2024. 100329. Epub 2024 Jan 6. PMID: 38237740.
- Suresh PS, Sun X, Zhou Z, Zhang Q. Spatial Proteomics Reveals Alcohol-Induced Damages to the Crypts and Villi of the Mouse Small Intestine. J Proteome Res. 2024;23(5):1801-9. Epub 20240424. doi: 10.1021/acs.jproteome.4c00037. PubMed PMID: 38655769; PMCID: PMC11077582.
- Hao L, Zhong W, Woo J, Wei X, Dong H, Guo W, Sun X, Yue R, Zhao J, Zhang Q, Zhou Z. Intestinal conventional type 1 dendritic cell protects against tight junction disruption via maintaining Akkermansia muciniphila abundance in alcoholic steatohepatitis. Hepatology. 2023 Sep 1;78(3):896-910. doi: 10.1097/HEP.0000000000000019. Epub 2023 Jan 3. PMID: 36626632.
- Dong H, Zhong W, Zhang W, Hao L, Guo W, Yue R, Sun X, Sun Z, Bataller R, Zhou Z. Loss of long-chain acyl-CoA synthetase 1 promotes hepatocyte death in alcohol-induced steatohepatitis. Metabolism. 2023 Jan; 138:155334. doi: 10.1016/j.metabol.2022.155334. Epub 2022 Oct 28. PMID: 36349655.
- Yue R, Wei X, Hao L, Dong H, Guo W, Sun X, Zhao J, Zhou Z, Zhong W. Promoting intestinal antimicrobial defense and microbiome symbiosis contributes to IL-22-mediated protection against alcoholic hepatitis in mice. Front Immunol. 2023 Oct 16; 14:1289356. doi: 10.3389/fimmu. 2023. 1289356. eCollection 2023. PMID: 37908362.
- Hao L, Zhong W, Dong H, Guo W, Sun X, Zhang W, Yue R, Li T, Griffiths A, Ahmadi AR, Sun Z, Song Z, Zhou Z. ATF4 activation promotes hepatic mitochondrial dysfunction by repressing NRF1-TFAM signaling in alcoholic steatohepatitis. Gut. 2021 Oct; 70(10):1933-1945. PMID: 33177163.
- Woo J, Schoenfeld M, Sun X, Iraguha T, Zhou Z, Zhang Q. Mouse Paneth Cell-Enriched Proteome Enabled by Laser Capture Microdissection. J Proteome Res. 2022;21(10):2435-42. Epub 20220925. doi: 10.1021/acs.jproteome.2c00311. PubMed PMID: 36153828; PMCID: PMC9671084.
- Yue R, Chen GY, Xie G, Hao L, Guo W, Sun X, Jia W, Zhang Q, Zhou Z, Zhong W. Activation of PPARα-catalase pathway reverses alcoholic liver injury via upregulating NAD synthesis and accelerating alcohol clearance. Free Radic Biol Med. 2021 Oct; 174:249-263. PMID: 34390780.
- Guo W, Zhong W, Hao L, Dong H, Sun X, Yue R, Li T, Zhou Z. Fatty Acids Inhibit LAMP2-Mediated Autophagy Flux via Activating ER Stress Pathway in Alcohol-Related Liver Disease. Cell Mol Gastroenterol Hepatol. 2021 July; 12(5):1599-1615. PMID: 34284164.
- Guo W, Zhong W, Hao L, Sun X, Zhou Z. Activation of mTORC1 by Free Fatty Acids Suppresses LAMP2 and Autophagy Function via ER Stress in Alcohol-Related Liver Disease. Cells. 2021 Oct 13; 10(10):2730. PMID: 34685712.
- Hao L, Zhong W, Sun X, Zhou Z. TLR9 Signaling Protects Alcohol-Induced Hepatic Oxidative Stress but Worsens Liver Inflammation in Mice. Front Pharmacol. 2021 Jun 28; 12:709002. PMID: 34262465
- Dong H, Hao L, Zhang W, Zhong W, Guo W, Yue R, Sun X, Zhou Z. Activation of AhR-NQO1 Signaling Pathway Protects Against Alcohol-Induced Liver Injury by Improving Redox Balance. Cell Mol Gastroenterol Hepatol. 2021 May; 12(3):793-811. PMID: 34082111.
- Yue R, Wei X, Zhao J, Zhou Z, Zhong W. Essential Role of IFN-γ in Regulating Gut microbial Peptides and Microbiota to Protect Against Alcohol-Induced Bacterial Translocation and Hepatic Inflammation in Mice. Front Physiol. 2021 Jan 18;11:629141. PMID: 33536944.
- Li T, Guo W, Zhou Z. Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology. Biomolecules. 2021 Dec 31;12(1):57. doi: 0.3390/biom12010057. PMID: 35053204.
- Song Q, Chen Y, Wang J, Hao L, Huang C, Griffiths A, Sun Z, Zhou Z, Song Z. ER Stress-Induced Upregulation of NNMT Contributes to Alcohol-Related Fatty Liver Development. J Hepatology 2020 Oct;73(4):783-793. PMID: 32389809
- Zhong W, Wei X, Hao L, Lin T-D, Yue R, Sun X, Guo W, Dong H, Li T, Ahmadi AR, Sun Z, Zhang Q, Zhao J, Zhou Z. Paneth cell dysfunction mediates alcoholic steatohepatitis through promoting bacterial translocation in mice: role of zinc deficiency. Hepatology 2020 May; 71(5):1575-1591. PMID: 31520476.
- Warner D, Joshi-Barve S, Feng W, Zhou Z, Zhong W, Seth D, Osna N, Kirpich I, McClain C. Mechanisms, Biomarkers and Targets for Therapy in Alcohol-associated Liver Injury: From Genetics to Nutrition: Summary of the ISBRA 2018 Symposium. Alcohol. 2020 Mar; 83:105-114. PMID: 31129175.
- Gao Y, Zhou Z, Ren TY, Kim S-J, He Y, Seo W, Guillot A, Ding Y, Wu R, Shao S, Wang X, He Y, Wang W, Feng D, Xu M, Zhong W, Zhou Z, Niu G, Gao B. Alcohol inhibits T-cell glucose metabolism and hepatitis in ALDH2-deficient mice and humans: Roles of acetaldehyde and glucocorticoids. Gut. 2019 Jul; 68(7):1311-1322. PMID: 30121625.
- Zhong W, Wei X, Hao L, Lin TD, Yue R, Sun X, Guo W, Dong H, Li T, Ahmadi AR, Sun Z, Zhang Q, Zhao J, Zhou Z. Paneth cell dysfunction mediates alcoholic steatohepatitis through promoting bacterial translocation in mice: role of zinc deficiency. Hepatology. 2019. doi: 10.1002/hep.30945. PubMed PMID: 31520476.
For earlier publications, see here.